NEW YORK (GenomeWeb) – Genomic Vision today announced that it has signed an agreement with APG Bio to distribute Genomic Vision's products and services to life science researchers in China, Hong Kong, and Macau.
Bagneux, France-based Genomic Vision markets its DNA Molecular Combing technology for genetic research applications including gene editing. It also provides a variety of molecular diagnostic tests for breast, ovarian, and colorectal cancers.
Terms of the agreement were not disclosed.
David Del Bourgo, director of marketing and sales for Genomic Vision, said in a statement that the alliance will "sustainably improve the international expansion" of the firm's life science research activities.
APG Bio is a Shanghai-based distributor of life science instruments and reagents.